Mgame (058630) 2026 stock outlook for international investors. A deep qualitative look at the aging MMORPG cash cows Hero Online and Knight Online, overseas royalties from China and Turkey, web-board and new-title options, and the small-cap volatility and loot-box regulation risks that come with this Korean game publisher.
Selvas AI (KOSDAQ 108860) 2026 stock analysis: two decades of Korean speech recognition (STT/TTS), handwriting and document OCR engines, on-device AI, the Selvas Healthcare link, generative-AI theme volatility, competition from Big Tech foundation models, valuation versus modest profit, governance risk, and how foreign investors access this Korea-listed AI small cap.
A qualitative 2026 outlook on VUNO (KOSDAQ 338220), Korea's AI medical imaging and biosignal diagnostics leader. How DeepCARS cardiac-arrest early warning, chest X-ray and brain MRI reading AI, reimbursement entry, and a US FDA push weigh against pre-profit cash burn, dilution, and small-cap volatility.
Viol (KOSDAQ 335890) 2026 stock outlook. A deep qualitative analysis of the Sylfirm X RF microneedling platform, the razor-blade model where devices seed recurring high-margin needle-tip sales, distributor-led expansion across the US, Europe, and the Middle East, competition from Classys, Wontech, Lutronic, and InMode, and the aesthetic-capex cycle risk that defines this Korean medtech name.
Vatech (KOSDAQ 043150) 2026 stock outlook for foreign investors. A qualitative deep dive into its 3D cone-beam CT, panoramic X-ray and intraoral scanner lineup, the analog-to-digital dentistry shift, AI-reading software and consumable recurring revenue, plus risks from dental capex cyclicality, currency swings and competition from Dentsply Sirona and Planmeca.
HD Hyundai Energy Solutions (KOSPI 322000) stock outlook for 2026. A qualitative deep dive into high-efficiency N-type modules, US residential and commercial demand, IRA and AMPC policy sensitivity, Chinese oversupply and price erosion, and the non-China US premium for foreign investors.